ММВБ 3 047 -0,1%  Nasdaq 11 881 0,2%  Биткойн 18 378 -0,1%  USD/RUB 76,0016 -0,1% 
РТС 1 257 -0,5%  S&P500 3 578 0,0%  Нефть 46,5 1,4%  EUR/RUB 90,0125 0,0% 
Dow 29 591 1,1%  FTSE100 6 334 -0,3%  Золото 1 826 -0,7%  EUR/USD 1,1845 0,1% 

Курс акций Cyclerion Therapeutics [ISIN: US23255M1053]

Cyclerion Therapeutics Inc Registered Shs When Issued - Профиль

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology. Its product pipeline includes several sGC stimulators, a small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate (cGMP). The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.


Название Доля (%)
Slate Path Capital LP18,27
Slate Path Capital LP18,27
American Endowment Foundation9,69
Camber Capital Management LP8,12
Ecor1 Capital LLC8,08
Fidelity Management & Research Co. LLC8,07
Wellington Management Co. LLP7,44
MFN Partners Management LP7,16
Invus Public Equities Advisors LLC6,78
Ecor1 Capital LLC6,59
MFN Partners Management LP5,50
Artal Group SA5,36
Vanguard Group, Inc. (Subfiler)5,00
Bridger Management LLC3,77




Добавить или редактировать инструмент